Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Woodbois looks to resume production as it faces cash crisis

(Sharecast News) - Woodbois said in an update on Wednesday that it was facing financial strain following last year's operational disruptions, which included a production halt and management changes. The AIM-traded company said it was experiencing tight working capital and an elevated level of creditors, but added that it expected cash generation to improve once production fully resumed, allowing it to normalise creditor payments within weeks.

It acknowledged that some creditors had grown impatient, a situation worsened by limited communication in late 2024.

A court in Gabon recently ruled in favor of BGFI Bank, permitting the institution to begin recovery proceedings for €0.79m owed by Woodbois.

The company maintained that resuming production was the best path forward for all stakeholders, including BGFI, employees in Gabon, and shareholders.

Woodbois said it had started shipping existing stock from the port in Libreville and was now moving additional inventory from its Mouila warehouse to the port.

The company added that it was in discussions with advisers regarding financing options to bridge its short-term working capital needs, and would provide further updates in due course.

At 1052 GMT, shares in Woodbois were down 10.55% at 0.07p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.